http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2022519343-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-00
filingDate 2020-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2022519343-A
titleOfInvention Benzodiazepine compound-containing pharmaceutical composition
abstract Means that can reduce the side effects of tolvaptan are provided. Specifically, equation (1) :. A pharmaceutical composition containing the formula (1) or a metal salt thereof, wherein 4 to 20 mg of the compound represented by the above or a metal salt thereof is used for transvascular administration over 10 minutes or more is provided.
priorityDate 2019-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009521397-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016533317-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015134837-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61488
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID141233
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448677000
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100151502
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397462
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP30518
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451609951
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454273629
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281642
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448981304
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161939
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP32307
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453063016
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID554
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100007585
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO88721
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450718528
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12000
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22242641
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID216237
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14818447
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID170206
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67519
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559485
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP48044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493608
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410135424
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403804
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25108
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18366337
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A5S6D8K1
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCNP_062009

Total number of triples: 59.